 Connection
Michel Chonchol to Hyperparathyroidism, Secondary
This is a "connection" page, showing publications Michel Chonchol has written about Hyperparathyroidism, Secondary.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.991 |
|
|
|
-
Kooienga L, Fried L, Scragg R, Kendrick J, Smits G, Chonchol M. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD. Am J Kidney Dis. 2009 Mar; 53(3):408-16.
Score: 0.326
-
Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco AL, Jolly S, Kaplan M, Roger SD, Sarkar S, Albizem MB, Mix TC, Kubo Y, Block GA. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis. 2009 Feb; 53(2):197-207.
Score: 0.324
-
Spiegel DM, Casey L, Bell S, Parker M, Chonchol M. Achieving targets for bone and mineral metabolism: the impact of cinacalcet HCl in clinical practice. Hemodial Int. 2006 Oct; 10 Suppl 2:S24-7.
Score: 0.277
-
Charytan C, Coburn JW, Chonchol M, Herman J, Lien YH, Liu W, Klassen PS, McCary LC, Pichette V. Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. Am J Kidney Dis. 2005 Jul; 46(1):58-67.
Score: 0.064
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|